95 related articles for article (PubMed ID: 21519017)
1. In situ DNA repair assays as guides to personalized breast cancer chemotherapeutics: ready for prime time?
Dent RA; Bristow RG
J Clin Oncol; 2011 Jun; 29(16):2130-2. PubMed ID: 21519017
[No Abstract] [Full Text] [Related]
2. An Achilles' heel for breast cancer?
Caldecott KW; Chalmers A
Nat Struct Mol Biol; 2005 May; 12(5):387-8. PubMed ID: 15870726
[No Abstract] [Full Text] [Related]
3. BRCA in breast cancer: from risk assessment to therapeutic prediction.
Diamond JR; Borges VF; Eckhardt SG; Jimeno A
Drug News Perspect; 2009 Dec; 22(10):603-8. PubMed ID: 20140280
[TBL] [Abstract][Full Text] [Related]
4. What's PARPing up for triple-negative breast cancer?
Sledge GW
Clin Breast Cancer; 2009 Aug; 9(3):139. PubMed ID: 19661035
[No Abstract] [Full Text] [Related]
5. Breast cancer management: opportunities and barriers to an individualized approach.
Perez EA
Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
[TBL] [Abstract][Full Text] [Related]
6. Personalized treatment of early-stage breast cancer: present concepts and future directions.
Harbeck N; Salem M; Nitz U; Gluz O; Liedtke C
Cancer Treat Rev; 2010 Dec; 36(8):584-94. PubMed ID: 20554119
[TBL] [Abstract][Full Text] [Related]
7. Innovative biomarker development for personalized medicine in breast cancer care.
Zografos GC; Roukos DH
Biomark Med; 2011 Feb; 5(1):73-8. PubMed ID: 21319967
[No Abstract] [Full Text] [Related]
8. PARP inhibition in breast cancer.
Garber J
Clin Adv Hematol Oncol; 2009 Sep; 7(9):573-5. PubMed ID: 20020667
[No Abstract] [Full Text] [Related]
9. 3-Aminobenzamide delays rejoining of DNA strand breaks in gamma-irradiated lymphocytes from patients with breast cancer and not cervical cancer.
Mukhopadhyay D; Anant S; Mukherji S
Neoplasma; 1994; 41(3):151-7. PubMed ID: 7935983
[TBL] [Abstract][Full Text] [Related]
10. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy.
Premkumar VG; Yuvaraj S; Shanthi P; Sachdanandam P
Br J Nutr; 2008 Dec; 100(6):1179-82. PubMed ID: 18377693
[TBL] [Abstract][Full Text] [Related]
11. [Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer].
Hashimoto K; Tamura K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1187-91. PubMed ID: 20647696
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibitors in breast cancer.
Telli ML; Ford JM
Clin Adv Hematol Oncol; 2010 Sep; 8(9):629-35. PubMed ID: 21157412
[TBL] [Abstract][Full Text] [Related]
13. Time to adapt.
Nature; 2010 Apr; 464(7293):1245-6. PubMed ID: 20428115
[No Abstract] [Full Text] [Related]
14. Molecular stratification of triple-negative breast cancers.
Perou CM
Oncologist; 2010; 15 Suppl 5():39-48. PubMed ID: 21138954
[TBL] [Abstract][Full Text] [Related]
15. Role of poly(ADP-ribose) formation in DNA repair.
Satoh MS; Lindahl T
Nature; 1992 Mar; 356(6367):356-8. PubMed ID: 1549180
[TBL] [Abstract][Full Text] [Related]
16. Markers of poly (ADP-ribose) polymerase activity as correlates of DNA damage.
Zhou Y; Liang S; Williams LR
Methods Mol Biol; 2002; 203():247-55. PubMed ID: 12073447
[No Abstract] [Full Text] [Related]
17. Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN).
Schmitt M; Lazar V
Bioanalysis; 2010 May; 2(5):851-3. PubMed ID: 21083216
[No Abstract] [Full Text] [Related]
18. Inhibition of poly(ADP-ribose) polymerase in cancer.
Plummer ER
Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
[TBL] [Abstract][Full Text] [Related]
19. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
Kaufmann M; Pusztai L;
Cancer; 2011 Apr; 117(8):1575-82. PubMed ID: 21472705
[TBL] [Abstract][Full Text] [Related]
20. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
Ratnam K; Low JA
Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
